Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Dec;23(12):e25649.
doi: 10.1002/jia2.25649.

Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs

Affiliations
Randomized Controlled Trial

Twenty-four-month outcomes from a cluster-randomized controlled trial of extending antiretroviral therapy refills in ART adherence clubs

Tali Cassidy et al. J Int AIDS Soc. 2020 Dec.

Abstract

Introduction: The antiretroviral therapy (ART) adherence club (AC) model has supported clinically stable HIV patients' retention with group ART refills and psychosocial support. Reducing visit frequency by increasing ART refills to six months could further benefit patients and unburden health systems. We conducted a pragmatic non-inferiority cluster randomized trial comparing standard of care (SoC) ACs and six-month refill intervention ACs in a primary care facility in Khayelitsha, South Africa.

Methods: Existing community-based and facility-based ACs were randomized to either SoC or intervention ACs. SoC ACs met five times annually, receiving two-month refills with a four-month refill over year-end. Blood was drawn at one AC visit with a clinical assessment at the next. Intervention ACs met twice annually receiving six-month refills, with an individual blood collection visit before the annual clinical assessment AC visit. The first study visits were in October and November 2017 and participants followed for 27 months. We report retention in care, viral load completion and viral suppression (<400 copies/mL) 24 months after enrolment and calculated intention-to-treat risk differences for the primary outcomes using generalized estimating equations specifying for clustering by AC.

Results: Of 2150 participants included in the trial, 977 were assigned to the intervention arm (40 ACs) and 1173 to the SoC (48 ACs). Patient characteristics at enrolment were similar across groups. Retention in care at 24 months was similarly high in both arms: 93.6% (1098/1173) in SoC and 92.6% (905/977) in the intervention arm, with a risk difference of -1.0% (95% CI: -3.2 to 1.3). The intervention arm had higher viral load completion (90.8% (999/1173) versus 85.1% (887/977)) and suppression (87.3% (969 /1173) versus 82.6% (853/977)) at 24 months, with a risk difference for completion of 5.5% (95% CI: 1.5 to 9.5) and suppression of 4.6% (95% CI: 0.2 to 9.0).

Conclusions: Intervention AC patients receiving six-month ART refills showed non-inferior retention in care, viral load completion and viral load suppression to those in SoC ACs, adding to a growing literature showing good outcomes with extended ART dispensing intervals.

Keywords: ART retention in care; HIV; adherence clubs; differentiated service delivery; multi-month dispensing; patient-centred.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparative SOC and Intervention AC schedule examples.
Figure 2
Figure 2
Study recruitment and enrolment flowchart.

References

    1. Johnson LF, May MT, Dorrington RE, Cornell M, Boulle A, Egger M, et al. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: a mathematical modelling study. PLoS Med. 2017;14(12):1–17. - PMC - PubMed
    1. Johnson L, Dorrington RE. Thembisa version 4.3: A model for evaluating the impact of HIV/AIDS in South Africa. 2020. (February 2014):1–164. Available from: https://www.thembisa.org/content/downloadPage/Thembisa4_3report Accessed 7 December 2020.
    1. Ehrenkranz P, Grimsrud A, Rabkin M. Differentiated service delivery: Navigating the path to scale. Curr Opin HIV AIDS. 2019;14(1):60–5. - PubMed
    1. Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression. J Int AIDS Soc. 2016;19(1):10–2. - PMC - PubMed
    1. International AIDS Society . Differentiated Care for HIV: A decision framework for antiretroviral therapy [Internet]. Durban: Int AIDS Soc. 2016;1–56. Available from: https://www.differentiatedcare.org/Portals/0/adam/Content/yS6M‐GKB5EWs_u...

Publication types

Substances